| [1] |
Siegel RL, Miller KD, Jema lA. Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67(3): 177-193.
|
| [2] |
Baade PD, Youlden DR, Cramb SM, et al. Epidemiology of peostate cancer in the Asia-Pacific region [J]. BJU Int, 2013, 112(5): 543-547.
|
| [3] |
Wu D, Ni J, Beretov J, et al. Urinary biomarkers in prostate cancer detection and monitoring progression[J]. Crit Rev Oncol Hematol，2017, 118(10): 356-375.
|
| [4] |
Anceschi U, Tuderti G, Lugnani F, et al. Novel diagnostic biomarkers of prostate cancer: an update[J]. Curr Med Chem, 2018, 9(13): 150-177.
|
| [5] |
Bussemakers MJ, van Bokhoven A, Verhaegh GW, et al. DD3: a new prostate-specifi c gene, highly overexpressed in prostate cancer [J]. Cancer Res, 1999, 59(23): 5975-5979.
|
| [6] |
Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostatecancer mortality in a randomized European study [J]. N Engl J Med, 2009, 360(10): 1320-1328.
|
| [7] |
何必鸣，陈锐，孙颖浩, 等. 长链非编码RNA作为诊断前列腺癌的标志物的现状 [J/CD]. 中华腔镜泌尿外科杂志(电子版), 2015, 9(3): 225-228.
|
| [8] |
Pang KH, Rosario DJ, Morgan SL, et al.Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies [J]. PLoS ONE, 2017, 12(4): 171-189.
|
| [9] |
Ploussard G, Haese A, Van Poppel H, et al. The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specifi c antigen ratio infl uence the performance of the PCA3 score in predicting positive biopsies [J]. BJU Int, 2010, 106(8): 143-1147.
|
| [10] |
Hansen J, Auprich M, Ahyai SA, et al. Initial prostate biopsy: development and internal validation of a biopsy-specifi c nomogram based on the prostate cancer antigen 3 assay [J]. Eur Urol, 2013, 63(2): 201-209.
|
| [11] |
Verbeek JFM, Bangma CH, Kweldam CF, et al. Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore [J]. Urol. Oncol, 2018, 37(2): 130-142.
|
| [12] |
Tosoian JJ, Patel HD, Mamawala M, et al. Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance[J]. Prostate Cancer Prostatic Dis, 2017, 20(3): 1-4.
|
| [13] |
Mao Z, Ji A, Yang K, et al. Diagnostic performance of PCA3 and hK2 in combination with serum PSA for prostate cancer[J]. Medicine (Baltimore) 2018 , 97(42): 56-361.
|
| [14] |
Bostwick DG, Gould VE, Qian J, et al. Prostate cancer detected by uPM3: radical prostatectomy findings [J]. Mod Pathol, 2017, 19(5): 630-633.
|
| [15] |
Nakanishi H, Groskopf J, Fritsche HA, et al. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance [J]. J Urol, 2008, 179(5): 1804-1809.
|
| [16] |
Whitman EJ, Groskopf J, Ali A, et al. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume [J]. J Urol, 2008, 180(5): 1975-1978.
|
| [17] |
Hessels D, Leyten GH, Smit FP, et al. Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer[J]. Clin. Cancer Res, 2015, 21(13):1-4.
|
| [18] |
Auprich M, Chun FK, Ward JF, et al. Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging[J]. Eur Urol, 2011, 59(1): 96-105.
|
| [19] |
Leyten GH, Hessels D, Jannink SA, et al. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer[J]. Eur Urol, 2014, 65(3): 534-542.
|
| [20] |
Sequeiros T, Bastarós JM, Sánchez M, et al. Urinary biomarkers for the detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia[J]. Prostate, 2015, 75(10): 1760-1767.
|
| [21] |
Cao L, Lee CH, Ning J, et al. Combination of prostate cancer antigen 3 and prostate-specific antigen improves diagnostic accuracy in men at risk of prostate cancer[J]. Arch. Pathol Lab Med, 2018, 142(9):107-193.
|
| [22] |
Vaananen RM, Rissanen M, Kauko O, et al. Quantitative realtime RT-PCR assay for PCA3[J]. Clin Biochem, 2008, 41(6): 103-108.
|
| [23] |
Neves AF, Dias-Oliveira JD, Araújo TG, et al. Prostate cancer antigen 3 (PCA3) RNA detection in blood and tissue samples for prostate cancer diagnosis[J]. Clin Chem Lab Med, 2013, 51(4): 881-887.
|
| [24] |
Jost M, Day JR, Slaughter R, et al. Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood[J]. Mol Cancer, 2015, 9(6): 174-181.
|
| [25] |
Fan JK, Wei N, Ding M, Gu JF,et al. Targeting Gene-ViroTherapy for prostate cancer by DD3-driven oncolytic virus-harboring interleukin-24 gene [J]. Int J Cancer, 2010, 127(3): 707-717.
|